202.76MMarket Cap-2013P/E (TTM)
4.5900High2.9400Low12.59MVolume4.4700Open6.1700Pre Close41.28MTurnover28.14%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.62P/B134.19MFloat Cap2.280052wk Low--Dividend TTM44.73MShs Float85.0000Historical High--Div YieldTTM26.74%Amplitude0.0300Historical Low3.2790Avg Price1Lot Size
Perspective Therapeutics Stock Forum
📊⚡️📊
Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
Perspective Therapeutics (NYSE AMERICAN: CATX) announced the upcoming presentation of initial results from their Phase 1/2a trial of [212Pb]VMT-α-NET at the 2024 NANETS Multidisciplinary NET Medical Symposium. The presentation, titled 'Preliminary safety and eff...
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$
$Perspective Therapeutics (CATX.US)$
1:10
$Virgin Galactic (SPCE.US)$ 1:20
$Star Equity (STRR.US)$ 1:5
$Workhorse (WKHS.US)$ 1:20
No comment yet